| Preoperative | 6 months after the operation | End of follow-up |
---|---|---|---|
Stage | |||
 Phase I | 24.7 ± 1.9 | 41.9 ± 3.5** | 45.6 ± 3.2** |
 Phase II | 22.4 ± 2.2 | 30.8 ± 6.6* | 26.0 ± 12.5 |
Pathogeny | |||
 AFHN | 24.2 ± 1.9 | 43.4 ± 2.8** | 47.2 ± 1.8** |
 SIFHN | 22.0 ± 2.6 | 27.3 ± 3.3* | 17.0 ± 2.9** |
 IFHN | 23.7 ± 2.4 | 34.8 ± 6.4* | 35.6 ± 11.1* |
Total | 23.4 ± 2.3 | 35.6 ± 7.8** | 34.6 ± 13.7* |